RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
종목 코드 RXST
회사 이름Rxsight Inc
상장일Jul 30, 2021
CEOKurtz (Ron M)
직원 수498
유형Ordinary Share
회계 연도 종료Jul 30
주소100 Columbia Street
도시ALISO VIEJO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호92656
전화19495217822
웹사이트https://www.rxsight.com/
종목 코드 RXST
상장일Jul 30, 2021
CEOKurtz (Ron M)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음